The Scientific Advisory Board advises the Board of Directors of the Princess Máxima Center on setting up the research program, the infrastructure, and strategic partnerships for research. The Board consists (inter)national members who have been asked to join on the basis of their exceptional knowledge and expertise in (pediatric) oncology research.
The Scientific Advisory Board of the Princess Máxima Center consists of the following distinguished members:
Prof. Dr. Martin Eilers (Chair)
Tumorigenesis, University of Würzburg, Biocenter, Würzburg, Germany
Prof. Dr. Ton Schumacher (Co-chair)
Cancer Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Prof. Dr. Richard Gilbertson
Cellular and molecular origins of cancer, University of Cambridge, Cambridge, UK
Prof. Dr. Anton Henssen
Experimental and Clinical Research Center (ECRC), Max Delbrück Center (MDC) and Charité University Hospital Berlin, Berlin, Germany
Prof. Dr. Anne May
Clinical epidemiology in cancer, UMC Utrecht, Utrecht, The Netherlands
Dr. Julie Park
Developmental and translational research for chilhood cancer, St. Jude Children's Research Hospital, Memphis, TN USA
Prof. Dr. Kimberley Stegmaier
Cancer Genomics, Dana Farber Cancer Institute, Boston, MA, USA